4 6 Net Leverage 1 Liquidity 2 Dividend per share 3 ANIMAL HEALTH CORPORATION I 12 Companion Animal Development Pipeline Oral Care (Cats and Dogs) Leverage Proprietary Vaccine Technologies to Increase Sales in Poultry Technologies MINERAL NUTRITION Adj. EBITDA $9m 10 Vaccines Derma care (Dogs) ▪ Development progress slowed due to COVID-19 Company Overview As of May 4, 2023 Important Information We use non-GAAP financial measures, such as adjusted EBITDA and adjusted net income, to assess and analyze our ope ...